3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
4
Interventional
1
Sponsor
Cancer Type
Breast
5
Myeloid
4
Lymphoid
4
Gynecologic
4
Other hematologic neoplasm
3
Thoracic
2
CNS
2
Plasma cell
1
Other neoplasm
1
NET
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Conditions
Multiple Myeloma
3082
Neoplasms, Plasma Cell
614
Lymphoma
455
Lymphoma, Non-Hodgkin
428
Recurrence
371
Hodgkin Disease
366
Leukemia, Lymphocytic, Chronic, B-Cell
362
Precursor Cell Lymphoblastic Leukemia-Lymphoma
340
Leukemia, Myeloid, Acute
322
Leukemia
321
Myelodysplastic Syndromes
287
Lymphoma, Mantle-Cell
262
Lymphoma, Large B-Cell, Diffuse
259
Lymphoma, Follicular
254
Lymphoma, B-Cell, Marginal Zone
231
Burkitt Lymphoma
227
Lymphoma, Large-Cell, Immunoblastic
203
Myeloproliferative Disorders
197
Immunoglobulin Light-chain Amyloidosis
184
Neoplasms
182
Hematologic Neoplasms
169
Primary Myelofibrosis
167
Leukemia, Myeloid, Chronic-Phase
165
Leukemia, Myeloid, Accelerated Phase
154
Lymphoma, T-Cell, Cutaneous
150
Waldenstrom Macroglobulinemia
145
Blast Crisis
143
Leukemia, Myelomonocytic, Chronic
140
Mycosis Fungoides
129
Sezary Syndrome
128
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hypersensitivity
×
Plasma cell
×
Clear all
NCT05001386
2022-03-17
ESAAC
Hospices Civils de Lyon
Phase NA
Unknown
800 enrolled